Search

everythinglearnresearchcommunity

for

Search:↓

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A man developed skin issues from cancer medication, which improved with specific treatments.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.